Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Publication year range
1.
Geobiology ; 15(6): 836-843, 2017 11.
Article in English | MEDLINE | ID: mdl-28851049

ABSTRACT

Demosponges are a rich natural source of unusual lipids, some of which are of interest as geochemical biomarkers. Although demosponges are animals, they often host dense communities of microbial symbionts, and it is therefore unclear which lipids can be synthesized by the animal de novo, and which require input from the microbial community. To address this uncertainty, we analyzed the lipids of Amphimdeon queenslandica, the only demosponge with a published genome. We correlated the genetic and lipid repertoires of A. queenslandica to identify which biomarkers could potentially be synthesized and/or modified by the sponge. The fatty acid profile of A. queenslandica is dominated by an unusual Δ5,9 fatty acid (cis-5,9-hexacosadienoic acid)-similar to what has been found in other members of the Amphimdeon genus-while the sterol profile is dominated by C27 -C29 derivatives of cholesterol. Based on our analysis of the A. queenslandica genome, we predict that this sponge can synthesize sterols de novo, but it lacks critical genes necessary to synthesize basic saturated and unsaturated fatty acids. However, it does appear to have the genes necessary to modify simpler products into a more complex "algal-like" assemblage of unsaturated fatty acids. Ultimately, our results provide additional support for the poriferan affinity of 24-isopropylcholestanes in Neoproterozoic-age rocks (the "sponge biomarker" hypothesis) and suggest that some algal proxies in the geochemical record could also have animal contributions.


Subject(s)
Genome , Lipid Metabolism , Porifera/genetics , Animals , Biomarkers/analysis , Paleontology , Porifera/metabolism , Queensland
2.
Sci Rep ; 6: 32550, 2016 08 31.
Article in English | MEDLINE | ID: mdl-27578547

ABSTRACT

The major histocompatibility complex (MHC, called HLA in humans) is an important genetic component of the immune system. Fish, birds and mammals prefer mates with different genetic MHC code compared to their own, which they determine using olfactory cues. This preference increases the chances of high MHC variety in the offspring, leading to enhanced resilience against a variety of pathogens. Humans are also able to discriminate HLA related olfactory stimuli, however, it is debated whether this mechanism is of behavioural relevance. We show on a large sample (N = 508), with high-resolution typing of HLA class I/II, that HLA dissimilarity correlates with partnership, sexuality and enhances the desire to procreate. We conclude that HLA mediates mate behaviour in humans.


Subject(s)
HLA Antigens/genetics , Olfactory Perception/physiology , Reproductive Behavior/physiology , Sexual Behavior/physiology , Smell/physiology , Adolescent , Adult , Female , Gene Expression , HLA Antigens/immunology , Histocompatibility Testing , Humans , Male , Middle Aged , Reproductive Behavior/psychology , Sequence Analysis, DNA , Sexual Behavior/psychology
3.
Metab Eng ; 29: 124-134, 2015 May.
Article in English | MEDLINE | ID: mdl-25792511

ABSTRACT

Some of the most productive metabolic engineering strategies involve genetic modifications that cause severe metabolic burden on the host cell. Growth-limiting genetic modifications can be more effective if they are 'switched on' after a population growth phase has been completed. To address this problem we have engineered dynamic regulation using a previously developed synthetic quorum sensing circuit in Saccharomyces cerevisiae. The circuit autonomously triggers gene expression at a high population density, and was linked with an RNA interference module to enable target gene silencing. As a demonstration the circuit was used to control flux through the shikimate pathway for the production of para-hydroxybenzoic acid (PHBA). Dynamic RNA repression allowed gene knock-downs which were identified by elementary flux mode analysis as highly productive but with low biomass formation to be implemented after a population growth phase, resulting in the highest published PHBA titer in yeast (1.1mM).


Subject(s)
Gene Expression Regulation, Fungal , Parabens/metabolism , Quorum Sensing/genetics , RNA Interference , Saccharomyces cerevisiae , Shikimic Acid/metabolism , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism
4.
Laryngorhinootologie ; 81(10): 702-5, 2002 Oct.
Article in German | MEDLINE | ID: mdl-12397519

ABSTRACT

BACKGROUND: Chondrosarcomas are rare malignant mesenchymal tumors of unknown etiology. Only 5 to 10 % appear in the head and neck region. PATIENT AND RESULTS: We report the case of a 63 year old woman with a chondrosarcoma of the sphenoethmoidal complex extending into the anterior cranial fossa. The tumor was subtotally resected via an osteoplastic lateral rhinotomy. Postoperatively, a fractionated radiation therapy with carbon ions (Schwerionen) was applied. There was no evidence of recurrence one year after therapy. CONCLUSION: Recent prognostic improvements of skull base chondrosarcomas by combination of skull base surgery and innovative radiation therapy are discussed and the literature is presented.


Subject(s)
Chondrosarcoma/diagnosis , Ethmoid Sinus , Paranasal Sinus Neoplasms/diagnosis , Sphenoid Sinus , Cell Division/physiology , Chondrosarcoma/pathology , Chondrosarcoma/surgery , Endoscopy , Ethmoid Sinus/pathology , Ethmoid Sinus/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Neoplasm Staging , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/surgery , Skull Base Neoplasms/diagnosis , Skull Base Neoplasms/pathology , Skull Base Neoplasms/surgery , Sphenoid Sinus/pathology , Sphenoid Sinus/surgery , Tomography, X-Ray Computed
8.
Arzneimittelforschung ; 41(6): 584-8, 1991 Jun.
Article in German | MEDLINE | ID: mdl-1930344

ABSTRACT

Clinical Efficacy of a Kava Extract in Patients with Anxiety Syndrome/Double-blind placebo controlled study over 4 weeks. In a randomized, placebo-controlled double-blind study two groups each containing 29 patients with anxiety syndrome not caused by psychotic disorders were treated for a period of 4 weeks with kava extract WS 1490 (Laitan) 3 x 100 mg/day or a placebo preparation. Therapeutic efficacy was assessed by the Hamilton-Anxiety-Scale (main target variable), the Adjectives-List and the Clinical-Global-Impression-Scale (secondary target variables) after 1, 2 and 4 weeks of treatment. The HAMA overall score of anxiety symptomatology revealed a significant reduction in the drug receiving group already after one week of treatment. This difference between the two groups of patients increased in the course of the study. The results of the secondary target variables were in agreement with the HAMA-score and demonstrate the efficacy of WS 1490 in patients with anxiety disorders. No adverse experiences caused by the medication were noted during the 4 week administration of WS 1490.


Subject(s)
Anxiety Disorders/drug therapy , Plant Extracts/therapeutic use , Adolescent , Adult , Anxiety Disorders/psychology , Double-Blind Method , Female , Humans , Kava , Male , Middle Aged , Plant Extracts/adverse effects , Plants, Medicinal , Psychiatric Status Rating Scales
SELECTION OF CITATIONS
SEARCH DETAIL